A detailed history of Wells Fargo & Company transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Wells Fargo & Company holds 2,500 shares of LEXX stock, worth $5,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,500
Previous 3,300 24.24%
Holding current value
$5,225
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$2.58 - $4.09 $2,064 - $3,272
-800 Reduced 24.24%
2,500 $7,000
Q2 2024

Aug 13, 2024

BUY
$1.99 - $4.0 $4,431 - $8,908
2,227 Added 207.55%
3,300 $9,000
Q1 2024

May 10, 2024

BUY
$1.29 - $6.25 $14 - $68
11 Added 1.04%
1,073 $3,000
Q4 2023

Feb 09, 2024

SELL
$0.92 - $1.69 $22 - $40
-24 Reduced 2.21%
1,062 $1,000
Q3 2023

Nov 13, 2023

BUY
$0.72 - $1.11 $10 - $16
15 Added 1.4%
1,086 $1,000
Q2 2023

Aug 15, 2023

BUY
$0.69 - $2.69 $1 - $5
2 Added 0.19%
1,071 $0
Q1 2023

May 12, 2023

BUY
$2.47 - $3.47 $83 - $117
34 Added 3.29%
1,069 $2,000
Q4 2022

Feb 13, 2023

BUY
$1.95 - $2.98 $1 - $2
1 Added 0.1%
1,035 $2,000
Q3 2022

Nov 14, 2022

BUY
$0.74 - $3.28 $1 - $6
2 Added 0.19%
1,034 $2,000
Q2 2022

Aug 12, 2022

BUY
$1.88 - $4.06 $3 - $8
2 Added 0.19%
1,032 $3,000
Q1 2022

May 16, 2022

BUY
$2.78 - $4.7 $13 - $23
5 Added 0.49%
1,030 $3,000
Q4 2021

Feb 14, 2022

BUY
$3.87 - $6.9 $3,870 - $6,900
1,000 Added 4000.0%
1,025 $4,000
Q3 2021

Nov 15, 2021

SELL
$5.39 - $8.44 $21 - $33
-4 Reduced 13.79%
25 $0
Q1 2021

May 13, 2021

BUY
$4.26 - $8.38 $123 - $243
29 New
29 $0

Others Institutions Holding LEXX

About Lexaria Bioscience Corp.


  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $12.4M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.